Second phase of clinical trial for promising COVID-19 drug begins
May 15, 2020
Second phase includes FDA-approved anti-inflammatory drug along with remdesivir.
Don’t let COVID-19 keep you from getting stroke care
May 13, 2020
Even during the COVID-19 pandemic, patients should never hesitate to call an ambulance if they have signs of a stroke
PSA: Cancer prevention and screening during the COVID-19 pandemic
May 7, 2020
Ruben Mesa, M.D., director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson, asks that the public keep their cancer screenings, tests and treatments during this time.
Cognition and gait speed often decline together, study shows
May 4, 2020
A study published by UT Health San Antonio researchers found that thinking and walking often parallel each other in determining a person’s health trajectory.
FDA gives emergency authorization to COVID-19 drug
May 4, 2020
Remdesivir is the first anti-viral drug that has been shown to benefit patients with COVID-19 in a randomized clinical trial.
Remdesivir showing success in combating COVID-19
April 30, 2020
Early results of a COVID-19 treatment study being conducted in San Antonio shows a faster recovery time and fewer deaths for patients.
